PK Study of Oral Rivaroxaban in Healthy Subjects.
Latest Information Update: 01 Feb 2017
At a glance
- Drugs Rivaroxaban (Primary)
- Indications Thrombosis
- Focus Pharmacokinetics
- Sponsors Janssen
- 29 Mar 2012 Actual patient number changed from 2 to 50 according to ClinicalTrials.gov.
- 29 Mar 2012 Actual end date (December 2011) added as reported by ClinicalTrials.gov.
- 29 Mar 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.